Time to HIV viral rebound and frequency of post-treatment control after analytical interruption of antiretroviral therapy: an individual data-based meta-analysis of 24 prospective studies
The only current strategy to test efficacy of novel interventions for sustained HIV control without antiretroviral therapy (ART) among people with HIV (PWH) is through an analytical treatment interruption (ATI). Inclusion of ‘placebo’ controls in ATIs poses ethical, logistical, and economic challeng...
Autors principals: | Gunst, JD, Gohil, J, Li, JZ, Bosch, RJ, White, Catherine Seamon, A, Chun, T, Mothe, B, Gittens, K, Praiss, L, De Scheerder, M, Vandekerckhove, L, Escandón, K, Thorkelson, A, Schacker, T, SenGupta, D, Brander, C, Papasavvas, E, Montaner, LJ, Martinez-Picado, J, Calin, R, Castagna, A, Muccini, C, de Jong, W, Leal, L, Tipoe, T, Frater, J |
---|---|
Format: | Journal article |
Idioma: | English |
Publicat: |
Nature Research
2025
|
Ítems similars
-
Time to HIV viral rebound and frequency of post-treatment control after analytical interruption of antiretroviral therapy: an individual data-based meta-analysis of 24 prospective studies
per: Jesper D. Gunst, et al.
Publicat: (2025-01-01) -
To rebound or not to rebound
per: Bethany A Stahl, et al.
Publicat: (2017-10-01) -
Phospholipid Metabolism Is Associated with Time to HIV Rebound upon Treatment Interruption
per: Leila B. Giron, et al.
Publicat: (2021-02-01) -
Immunological biomarkers predict HIV-1 viral rebound after treatment interruption
per: Hurst, J, et al.
Publicat: (2015) -
Operational complexity and supplier-customer integration: case study insights and complexity rebound.
per: Sivadasan, S, et al.
Publicat: (2010)